Please try another search
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
Name | Age | Since | Title |
---|---|---|---|
Robert William Schafer | 68 | 2006 | Independent Non-Executive Chairman |
Paul Terence Gazzard | 49 | 2016 | Independent Non-Executive Director |
Thomas Edward Bowens | 58 | 2019 | Independent Non-Executive Director |
Robin Jay Young | 66 | 2004 | CEO, Secretary & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review